On January 5, 2015, the board of directors of Echo Therapeutics, Inc. appointed Scott W. Hollander, the company's president and chief executive officer, to fill a vacancy on the board. Mr. Hollander will serve as a Class I director of the company.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+8.88% | 221B | |
+8.68% | 186B | |
+14.25% | 137B | |
+28.18% | 109B | |
+14.65% | 52.68B | |
+4.48% | 50.86B | |
+4.39% | 42.53B | |
+7.00% | 37.76B | |
+26.06% | 31.86B |